 | • レポートコード：D005-00437 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、泌尿生殖器薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。泌尿生殖器薬の種類別市場規模（泌尿器科、ホルモン療法、婦人科、抗感染薬）、用途別市場規模（前立腺がん、卵巣がん、膀胱がん、子宮頸がん、腎がん、勃起不全、尿路感染症、尿失禁、過活動膀胱、性感染症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis AG、Genentech ・地域別グローバル市場分析 2015年-2020年 ・泌尿生殖器薬の北米市場（アメリカ、カナダ、メキシコ） ・泌尿生殖器薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・泌尿生殖器薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・泌尿生殖器薬の南米市場（ブラジル、アルゼンチン） ・泌尿生殖器薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：泌尿器科、ホルモン療法、婦人科、抗感染薬 ・用途別分析：前立腺がん、卵巣がん、膀胱がん、子宮頸がん、腎がん、勃起不全、尿路感染症、尿失禁、過活動膀胱、性感染症 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Genitourinary Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Genitourinary Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Genitourinary Drugs market has been segmented into:
Urologicals
Hormonal Therapy
Gynecological
Anti-infectives
By Application, Genitourinary Drugs has been segmented into:
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence & Overactive Bladder
Sexually Transmitted Diseases
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Genitourinary Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Genitourinary Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genitourinary Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Genitourinary Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Genitourinary Drugs Market Share Analysis
Genitourinary Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genitourinary Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genitourinary Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Genitourinary Drugs are:
Novartis AG
Genentech
Table of Contents
1 Genitourinary Drugs Market Overview
1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs by Type
1.2.1 Global Genitourinary Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Genitourinary Drugs Revenue Market Share by Type in 2019
1.2.3 Urologicals
1.2.4 Hormonal Therapy
1.2.5 Gynecological
1.2.6 Anti-infectives
1.3 Global Genitourinary Drugs Market by Application
1.3.1 Overview: Global Genitourinary Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prostate Cancer
1.3.3 Ovarian Cancer
1.3.4 Bladder Cancer
1.3.5 Cervical Cancer
1.3.6 Renal Cancer
1.3.7 Erectile Dysfunction
1.3.8 Urinary Tract Infections
1.3.9 Urinary Incontinence & Overactive Bladder
1.3.10 Sexually Transmitted Diseases
1.4 Global Genitourinary Drugs Market by Regions
1.4.1 Global Genitourinary Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Genitourinary Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Genitourinary Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Genitourinary Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genitourinary Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Genitourinary Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genitourinary Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis AG SWOT Analysis
2.1.4 Novartis AG Product and Services
2.1.5 Novartis AG Genitourinary Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genentech
2.2.1 Genentech Details
2.2.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genentech SWOT Analysis
2.2.4 Genentech Product and Services
2.2.5 Genentech Genitourinary Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Genitourinary Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Genitourinary Drugs Players Market Share
3.2.2 Top 10 Genitourinary Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Genitourinary Drugs Revenue and Market Share by Regions
4.2 North America Genitourinary Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Genitourinary Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Genitourinary Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Genitourinary Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Genitourinary Drugs Revenue and Growth Rate (2015-2020)
5 North America Genitourinary Drugs Revenue by Countries
5.1 North America Genitourinary Drugs Revenue by Countries (2015-2020)
5.2 USA Genitourinary Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Genitourinary Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Genitourinary Drugs Revenue and Growth Rate (2015-2020)
6 Europe Genitourinary Drugs Revenue by Countries
6.1 Europe Genitourinary Drugs Revenue by Countries (2015-2020)
6.2 Germany Genitourinary Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Genitourinary Drugs Revenue and Growth Rate (2015-2020)
6.4 France Genitourinary Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Genitourinary Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Genitourinary Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Genitourinary Drugs Revenue by Countries
7.1 Asia-Pacific Genitourinary Drugs Revenue by Countries (2015-2020)
7.2 China Genitourinary Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Genitourinary Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Genitourinary Drugs Revenue and Growth Rate (2015-2020)
7.5 India Genitourinary Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Genitourinary Drugs Revenue and Growth Rate (2015-2020)
8 South America Genitourinary Drugs Revenue by Countries
8.1 South America Genitourinary Drugs Revenue by Countries (2015-2020)
8.2 Brazil Genitourinary Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Genitourinary Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Genitourinary Drugs by Countries
9.1 Middle East & Africa Genitourinary Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Genitourinary Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Genitourinary Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Genitourinary Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Genitourinary Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Genitourinary Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Genitourinary Drugs Market Forecast by Type (2019-2024)
10.3 Urologicals Revenue Growth Rate (2015-2025)
10.4 Hormonal Therapy Revenue Growth Rate (2015-2025)
10.5 Gynecological Revenue Growth Rate (2015-2025)
10.6 Anti-infectives Revenue Growth Rate (2015-2025)
11 Global Genitourinary Drugs Market Segment by Application
11.1 Global Genitourinary Drugs Revenue Market Share by Application (2015-2020)
11.2 Genitourinary Drugs Market Forecast by Application (2019-2024)
11.3 Prostate Cancer Revenue Growth (2015-2020)
11.4 Ovarian Cancer Revenue Growth (2015-2020)
11.5 Bladder Cancer Revenue Growth (2015-2020)
11.6 Cervical Cancer Revenue Growth (2015-2020)
11.7 Renal Cancer Revenue Growth (2015-2020)
11.8 Erectile Dysfunction Revenue Growth (2015-2020)
11.9 Urinary Tract Infections Revenue Growth (2015-2020)
11.10 Urinary Incontinence & Overactive Bladder Revenue Growth (2015-2020)
11.11 Sexually Transmitted Diseases Revenue Growth (2015-2020)
12 Global Genitourinary Drugs Market Size Forecast (2021-2025)
12.1 Global Genitourinary Drugs Market Size Forecast (2021-2025)
12.2 Global Genitourinary Drugs Market Forecast by Regions (2021-2025)
12.3 North America Genitourinary Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Genitourinary Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Genitourinary Drugs Revenue Market Forecast (2021-2025)
12.6 South America Genitourinary Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Genitourinary Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Genitourinary Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Genitourinary Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Genitourinary Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Genitourinary Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis AG Corporate Information, Location and Competitors
Table 6. Novartis AG Genitourinary Drugs Major Business
Table 7. Novartis AG Genitourinary Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Novartis AG SWOT Analysis
Table 9. Novartis AG Genitourinary Drugs Product and Solutions
Table 10. Novartis AG Genitourinary Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Genentech Corporate Information, Location and Competitors
Table 12. Genentech Genitourinary Drugs Major Business
Table 13. Genentech Genitourinary Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Genentech SWOT Analysis
Table 15. Genentech Genitourinary Drugs Product and Solutions
Table 16. Genentech Genitourinary Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Global Genitourinary Drugs Revenue (Million USD) by Players (2015-2020)
Table 18. Global Genitourinary Drugs Revenue Share by Players (2015-2020)
Table 19. Global Genitourinary Drugs Revenue (Million USD) by Regions (2015-2020)
Table 20. Global Genitourinary Drugs Revenue Market Share by Regions (2015-2020)
Table 21. North America Genitourinary Drugs Revenue by Countries (2015-2020)
Table 22. North America Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Table 23. Europe Genitourinary Drugs Revenue (Million USD) by Countries (2015-2020)
Table 24. Asia-Pacific Genitourinary Drugs Revenue (Million USD) by Countries (2015-2020)
Table 25. South America Genitourinary Drugs Revenue by Countries (2015-2020)
Table 26. South America Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Table 27. Middle East and Africa Genitourinary Drugs Revenue (Million USD) by Countries (2015-2020)
Table 28. Middle East and Africa Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Table 29. Global Genitourinary Drugs Revenue (Million USD) by Type (2015-2020)
Table 30. Global Genitourinary Drugs Revenue Share by Type (2015-2020)
Table 31. Global Genitourinary Drugs Revenue Forecast by Type (2021-2025)
Table 32. Global Genitourinary Drugs Revenue by Application (2015-2020)
Table 33. Global Genitourinary Drugs Revenue Share by Application (2015-2020)
Table 34. Global Genitourinary Drugs Revenue Forecast by Application (2021-2025)
Table 35. Global Genitourinary Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Genitourinary Drugs Picture
Figure 2. Global Genitourinary Drugs Revenue Market Share by Type in 2019
Figure 3. Urologicals Picture
Figure 4. Hormonal Therapy Picture
Figure 5. Gynecological Picture
Figure 6. Anti-infectives Picture
Figure 7. Genitourinary Drugs Revenue Market Share by Application in 2019
Figure 8. Prostate Cancer Picture
Figure 9. Ovarian Cancer Picture
Figure 10. Bladder Cancer Picture
Figure 11. Cervical Cancer Picture
Figure 12. Renal Cancer Picture
Figure 13. Erectile Dysfunction Picture
Figure 14. Urinary Tract Infections Picture
Figure 15. Urinary Incontinence & Overactive Bladder Picture
Figure 16. Sexually Transmitted Diseases Picture
Figure 17. Global Genitourinary Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. North America Genitourinary Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Europe Genitourinary Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Asia-Pacific Genitourinary Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. South America Genitourinary Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Middle East and Africa Genitourinary Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Genitourinary Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Genitourinary Drugs Revenue Share by Players in 2019
Figure 25. Global Top 5 Players Genitourinary Drugs Revenue Market Share in 2019
Figure 26. Global Top 10 Players Genitourinary Drugs Revenue Market Share in 2019
Figure 27. Key Players Market Share Trend
Figure 28. Global Genitourinary Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 29. Global Genitourinary Drugs Revenue Market Share by Regions (2015-2020)
Figure 30. Global Genitourinary Drugs Revenue Market Share by Regions in 2018
Figure 31. North America Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Europe Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Asia-Pacific Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 34. South America Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Middle East and Africa Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 36. North America Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Figure 37. North America Genitourinary Drugs Revenue Market Share by Countries in 2019
Figure 38. USA Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Canada Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Mexico Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Europe Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Figure 42. Europe Genitourinary Drugs Revenue Market Share by Countries in 2019
Figure 43. Germany Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 44. UK Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 45. France Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Russia Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Italy Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Figure 49. Asia-Pacific Genitourinary Drugs Revenue Market Share by Countries in 2019
Figure 50. China Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Japan Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Korea Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 53. India Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Southeast Asia Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 55. South America Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. South America Genitourinary Drugs Revenue Market Share by Countries in 2019
Figure 57. Brazil Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Argentina Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Middle East and Africa Genitourinary Drugs Revenue Market Share by Countries (2015-2020)
Figure 60. Middle East and Africa Genitourinary Drugs Revenue Market Share by Countries in 2019
Figure 61. Saudi Arabia Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 62. UAE Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 63. Egypt Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 64. South Africa Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Figure 65. Global Genitourinary Drugs Revenue Share by Type (2015-2020)
Figure 66. Global Genitourinary Drugs Revenue Share by Type in 2019
Figure 67. Global Genitourinary Drugs Market Share Forecast by Type (2021-2025)
Figure 68. Global Urologicals Revenue Growth Rate (2015-2020)
Figure 69. Global Hormonal Therapy Revenue Growth Rate (2015-2020)
Figure 70. Global Gynecological Revenue Growth Rate (2015-2020)
Figure 71. Global Anti-infectives Revenue Growth Rate (2015-2020)
Figure 72. Global Genitourinary Drugs Revenue Share by Application (2015-2020)
Figure 73. Global Genitourinary Drugs Revenue Share by Application in 2019
Figure 74. Global Genitourinary Drugs Market Share Forecast by Application (2021-2025)
Figure 75. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 76. Global Ovarian Cancer Revenue Growth Rate (2015-2020)
Figure 77. Global Bladder Cancer Revenue Growth Rate (2015-2020)
Figure 78. Global Cervical Cancer Revenue Growth Rate (2015-2020)
Figure 79. Global Renal Cancer Revenue Growth Rate (2015-2020)
Figure 80. Global Erectile Dysfunction Revenue Growth Rate (2015-2020)
Figure 81. Global Urinary Tract Infections Revenue Growth Rate (2015-2020)
Figure 82. Global Urinary Incontinence & Overactive Bladder Revenue Growth Rate (2015-2020)
Figure 83. Global Sexually Transmitted Diseases Revenue Growth Rate (2015-2020)
Figure 84. Global Genitourinary Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 85. Global Genitourinary Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 86. Global Genitourinary Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 87. North America Genitourinary Drugs Revenue Market Forecast (2021-2025)
Figure 88. Europe Genitourinary Drugs Revenue Market Forecast (2021-2025)
Figure 89. Asia-Pacific Genitourinary Drugs Revenue Market Forecast (2021-2025)
Figure 90. South America Genitourinary Drugs Revenue Market Forecast (2021-2025)
Figure 91. Middle East and Africa Genitourinary Drugs Revenue Market Forecast (2021-2025)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
骨髄異形成症候群（MDS）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Myelodysplastic Syndrome (MDS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1798.3 million by 2025, from USD 1452.7 million in 2019. The…- 自殺防止薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Suicide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 3696 million by 2025, from USD 3384.6 million in 2019. The Anti-Suicide Drugs …
- 結核薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tuberculosis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 965.3 million by 2025, from USD 863.6 million in 2019. The Tuberculosis Drugs …
- 尿路上皮がん治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Urothelial Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1565.9 million by 2025, from USD 980.1 million in 2019. The Urothelial C…
- バーター症候群薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome Drugs…